Machine Learning Modeling Of SiRNA Structure-Potency Relationship With Applications Against Sars-Cov-2 Spike Gene

• URL: http://arxiv.org/abs/2401.12232v1
• Date: Thu, 18 Jan 2024 23:00:34 GMT
• Title: Machine Learning Modeling Of SiRNA Structure-Potency Relationship With Applications Against Sars-Cov-2 Spike Gene
• Authors: Damilola Oshunyinka
• Abstract summary: Drug discovery process is lengthy and costly, taking nearly a decade to bring a new drug to the market. Biotechnology, computational methods, and machine learning algorithms have the potential to revolutionize drug discovery, speeding up the process and improving patient outcomes. The COVID-19 pandemic has further accelerated and deepened the recognition of the potential of these techniques, especially in the areas of drug repurposing and efficacy predictions.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: The pharmaceutical Research and development (R&D) process is lengthy and costly, taking nearly a decade to bring a new drug to the market. However, advancements in biotechnology, computational methods, and machine learning algorithms have the potential to revolutionize drug discovery, speeding up the process and improving patient outcomes. The COVID-19 pandemic has further accelerated and deepened the recognition of the potential of these techniques, especially in the areas of drug repurposing and efficacy predictions. Meanwhile, non-small molecule therapeutic modalities such as cell therapies, monoclonal antibodies, and RNA interference (RNAi) technology have gained importance due to their ability to target specific disease pathways and/or patient populations. In the field of RNAi, many experiments have been carried out to design and select highly efficient siRNAs. However, the established patterns for efficient siRNAs are sometimes contradictory and unable to consistently determine the most potent siRNA molecules against a target mRNA. Thus, this paper focuses on developing machine learning models based on the cheminformatics representation of the nucleotide composition (i.e. AUTGC) of siRNA to predict their potency and aid the selection of the most efficient siRNAs for further development. The PLS (Partial Least Square) and SVR (Support Vector Regression) machine learning models built in this work outperformed previously published models. These models can help in predicting siRNA potency and aid in selecting the best siRNA molecules for experimental validation and further clinical development. The study has demonstrated the potential of AI/machine learning models to help expedite siRNA-based drug discovery including the discovery of potent siRNAs against SARS-CoV-2.

Related papers

• DeepFM-Crispr: Prediction of CRISPR On-Target Effects via Deep Learning [0.24554686192257422]
  DeepFM-Crispr is a novel deep learning model developed to predict the on-target efficiency and evaluate the off-target effects of Cas13d. It harnesses a large language model to generate comprehensive representations rich in evolutionary and structural data, thereby enhancing predictions of RNA secondary structures and overall sgRNA efficacy.
  arXiv  Detail & Related papers  (2024-09-09T17:33:54Z)
• BEACON: Benchmark for Comprehensive RNA Tasks and Language Models [60.02663015002029]
  We introduce the first comprehensive RNA benchmark BEACON (textbfBEnchmtextbfArk for textbfCOmprehensive RtextbfNA Task and Language Models). First, BEACON comprises 13 distinct tasks derived from extensive previous work covering structural analysis, functional studies, and engineering applications. Second, we examine a range of models, including traditional approaches like CNNs, as well as advanced RNA foundation models based on language models, offering valuable insights into the task-specific performances of these models. Third, we investigate the vital RNA language model components
  arXiv  Detail & Related papers  (2024-06-14T19:39:19Z)
• Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
  Conditional generation based on the target IC50 score can obtain a more effective sampling space. Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
  arXiv  Detail & Related papers  (2024-05-23T13:22:17Z)
• CRISPR: Ensemble Model [20.268713698436326]
  We propose a novel ensemble learning method for sgRNA design that is accurate and generalizable. Our results suggest that our method can be used to design sgRNAs with high sensitivity and specificity, even for new genes or cells.
  arXiv  Detail & Related papers  (2024-03-05T14:55:14Z)
• scHyena: Foundation Model for Full-Length Single-Cell RNA-Seq Analysis in Brain [46.39828178736219]
  We introduce scHyena, a foundation model designed to address these challenges and enhance the accuracy of scRNA-seq analysis in the brain. scHyena is equipped with a linear adaptor layer, the positional encoding via gene-embedding, and a bidirectional Hyena operator. This enables us to process full-length scRNA-seq data without losing any information from the raw data.
  arXiv  Detail & Related papers  (2023-10-04T10:30:08Z)
• Knowledge from Large-Scale Protein Contact Prediction Models Can Be Transferred to the Data-Scarce RNA Contact Prediction Task [40.051834115537474]
  We find that a protein-coevolution Transformer-based deep neural network can be transferred to the RNA contact prediction task. Experiments confirm that RNA contact prediction through transfer learning is greatly improved. Our findings indicate that the learned structural patterns of proteins can be transferred to RNAs, opening up potential new avenues for research.
  arXiv  Detail & Related papers  (2023-02-13T06:00:56Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• E2Efold-3D: End-to-End Deep Learning Method for accurate de novo RNA 3D Structure Prediction [46.38735421190187]
  We develop the first end-to-end deep learning approach, E2Efold-3D, to accurately perform the textitde novo RNA structure prediction. Several novel components are proposed to overcome the data scarcity, such as a fully-differentiable end-to-end pipeline, secondary structure-assisted self-distillation, and parameter-efficient backbone formulation.
  arXiv  Detail & Related papers  (2022-07-04T17:15:35Z)
• Improving RNA Secondary Structure Design using Deep Reinforcement Learning [69.63971634605797]
  We propose a new benchmark of applying reinforcement learning to RNA sequence design, in which the objective function is defined to be the free energy in the sequence's secondary structure. We show results of the ablation analysis that we do for these algorithms, as well as graphs indicating the algorithm's performance across batches.
  arXiv  Detail & Related papers  (2021-11-05T02:54:06Z)
• Predictive models of RNA degradation through dual crowdsourcing [2.003083111563343]
  We describe a crowdsourced machine learning competition ("Stanford OpenVaccine") on Kaggle. Winning models demonstrated test set errors that were better by 50% than the previous state-of-the-art DegScore model.
  arXiv  Detail & Related papers  (2021-10-14T16:50:37Z)
• Machine learning for plant microRNA prediction: A systematic review [0.0]
  MicroRNAs (miRNAs) are endogenous small non-coding RNAs that play an important role in gene regulation. computational and machine learning-based approaches have been adopted to predict microRNAs. This systematic review focuses on the machine learning methods developed for identification in plants.
  arXiv  Detail & Related papers  (2021-06-29T08:22:57Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.